This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Linda W. Martin, M.D., M.P.H.
University of Virginia Thoracic Cardiovascular Surgery
Assistant Professor, Stanford Cardiothoracic Surgery
Assistant Professor, University of Maryland Thoracic Surgery
Associate Professor, University of Virginia Thoracic Surgery 2016 - 2021
Associate Professor with Tenure, University of Virginia Thoracic Surgery 2021 - present
Clerkship Director, Dept of Surgery, University of Virginia 2018-present
Associate Program Director, Cardiothoracic and I-6 Residency, University of Virginia 2019-present
Interim Chief, Division of Thoracic Surgery, UVA, 2020-present
Multimodality Therapy for Lung Cancer
Mediastinal and Chest Wall Tumors
Lung Cancer Surgery
Lung Cancer Screening
Endobronchial Ultrasound (EBUS)
Esophageal Cancer Surgery and Multimodality Therapy
Minimally Invasive Surgery for Benign Esophageal Diseases
Robotic Thoracic Surgery
Enhanced Recovery Pathways
Immunotherapy for Thoracic Malignancies
NCT04062708 Alliance Foundation Trial 46: CHIO3: Chemotherapy Combined with Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Lung Cancer. Study Chair.
NCT 02856581 Alliance Trial A211401 Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients with Newly Diagnosed Lung Cancer Who Smoke Cigarettes (closed)
NCT02468024 Stablemates Trial: Sublobar Resection vs. SBRT for high risk operable early stage lung cancer
NCT03425643 Keynote 671: Efficacy and Safety of Pembrolizumab with Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants wiht Resectable stage IIB or IIIA Non-Small Cell Lung Cancer
NCT02194738 ALCHEMIST Trial and related trials (ANVIL, et al.)
NCT03228537 SWOG 1619: Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma
NCT04241315 ELUCIDATE: Enabling LUng Cancer IDentification Using folATE Receptor Targeting. On Target Laboratories. Steering Committee, site PI.
Additional Educational Information
UCLA (B.S. Biology)
UCSD School of Medicine (M.D.)
University of Minnesota General Surgery Residency
UCSF General Surgery Residency
MD Anderson Cancer Center/Texas Heart Institute Thoracic Track Residency
Clinical Research Fellow, MD Anderson Cancer Center Thoracic Surgery
U.T. Houston School of Public Health (M.P.H.)
Content Published on CTSNet
- Minimally Invasive
- Chest wall
- Trachea and bronchi
- Professional Affairs